Remifentanil Hydrochloride Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Remifentanil Hydrochloride Injection (injection) from Hikma Pharmaceuticals USA, Inc. with status Current. The shortage was first posted on Jun 28, 2022. Reported reason: Demand increase for the drug
Shortage details
- Status
- Current
- Company
- Hikma Pharmaceuticals USA, Inc.
- Package NDC
- 0143-9391-10
- Dosage Form
- Injection
- Presentation
- Remifentanil Hydrochloride, Injection, 1 mg per vial (NDC 0143-9391-10)
- Initial Posting
- Jun 28, 2022
Reason
Demand increase for the drug